SCHEMBL14934

SCHEMBL14934

NCC(=O)NCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19434714 1.00 GLRA1 (0.47)
SCHEMBL29952010 1.00
Water SCHEMBL28405902 0.97 GLRA1 (0.45)
SCHEMBL9812291 0.97 GLRA1 (0.45)
SCHEMBL29749319 0.97 GLRA1 (0.45)
Bicarbonate SCHEMBL7624841 0.97 GLRA1 (0.45)
SCHEMBL11249096 0.97 GLRA1 (0.45)
Glycine SCHEMBL1234586 0.97 GLRA1 (0.53)
Glycine SCHEMBL1626730 0.97 GLRA1 (0.53)
Hydrochloric Acid SCHEMBL2452130 0.97 GLRA1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 118801 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146354-A1 STEEL SHEET HAVING EXCELLENT PLATING QUALITY AND METHOD FOR MANUFACTURING SAME POSCO CO., LTD (KR) 2026-05-28 US claimed
US-20260144815-A1 BLOOD COAGULATION TIME SHORTENING AGENT FOR BLOOD SPECIMEN DEFICIENT IN COAGULATION FACTOR XII SEKISUI MEDICAL CO., LTD. (JP) 2026-05-28 US claimed
EP-4743120-A1 MOLECULAR DEGRADERS FOR THE TREATMENT OF IGA NEPHROPATHY Biohaven Therapeutics Ltd. (VG) 2026-05-20 EP claimed
WO-2026101351-A1 METHOD FOR PREPARING LIPID NANOPARTICLES 주식회사 테르나테라퓨틱스 2026-05-15 WO claimed
EP-4739416-A1 METHOD OF PURIFICATION CSL Behring AG (CH) 2026-05-13 EP claimed
EP-4739992-A1 DETECTION OF TARGET MOLECULES IN DRIED BIOLOGIC MATRICES SomaLogic Operating Co., Inc. (US) 2026-05-13 EP claimed
US-12622975-B2 Peptide-conjugated prodrugs BRANDEIS UNIVERSITY (US) 2026-05-12 US claimed
CN-119614203-B Etching solution for selectively etching silicon nitride and silicon oxide and titanium nitride 湖北兴福电子材料股份有限公司 2026-05-12 CN claimed
EP-4735021-A1 COMBINATION THERAPY Zealand Pharma A/S (DK) 2026-05-06 EP claimed
WO-2026085618-A1 METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION YYZ PHARMATECH INC. (CA) 2026-04-30 WO claimed
EP-0085348-A1 Reagents for the determination of enzymes AMERICAN HOECHST CORPORATION (US) 1983-08-10 EP claimed
EP-0048347-B1 PROCESS AND REAGENT FOR THE DETERMINATION OF GLYCEROL Roche Diagnostics GmbH (DE) 1983-07-27 EP claimed
EP-0082015-A1 Method of forming an image with a photographic cuprous halide material KONICA CORPORATION (JP) 1983-06-22 EP claimed
US-4376827-A Composition, test device and method for determining the ionic strength or specific gravity of a liquid sample utilizing a strong polyelectrolyte MILES LABORATORIES, INC. (US) 1983-03-15 US claimed
EP-0023631-B1 MEANS AND METHOD FOR DETERMINING THE IONIC STRENGTH OR SPECIFIC GRAVITY OF AN AQUEOUS TEST SAMPLE MILES LABORATORIES, INC. (US) 1983-02-16 EP claimed
EP-0023631-A1 Means and method for determining the ionic strength or specific gravity of an aqueous test sample MILES LABORATORIES, INC. (US) 1981-02-11 EP claimed
US-4246084-A BARBITAL AND GLYCINE-TYPE BUFFERS ENHANCE THE DIAGNOSTIC USEFULNESS BECKMAN INSTRUMENTS, INC. (US) 1981-01-20 US claimed
US-4167449-A Composition and method for determining transferase and protease activity AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1979-09-11 US claimed
US-4024237-A Novel compositions for establishing environmental conditions favorable to oral leucocytes EICHEL BERTRAM 1977-05-17 US claimed
US-3986931-A γ-GLUTAMYL-4-NITROANILIDE COMPOUNDS AND THEIR USE IN DETERMINING γ-GLUTAMYL TRANSPEPTIDASE BOEHRINGER MANNHEIM G.M.B.H. (DT) 1976-10-19 US claimed